Donanemab: Eli Lilly Alzheimer’s Medication Explained
Donanemab is a medicine designed by Eli Lilly for the treatment of Alzheimer’s. In a May 2023 announcement, the company said that it found in trials that Donanemab slowed the decline in the ability of Alzheimer’s patients to perform daily tasks and think clearly. Donanemab News Timeline Study Finds Donanemab Helps Alzheimer’s Patients. “The medicine, … Read more